MedTrace Logo

Topera C-FIRM Registry

NCT02407249 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2019-10-16

Study results available
· View outcomes & findings →

Summary

This is a control registry to the E-FIRM registry to track conventional atrial fibrillation (AF) procedures in terms of clinical usage, handling, and the safety and effectiveness for the treatment of symptomatic atrial fibrillation. Conventional AF ablation is defined as pulmonary vein isolation (PVI) and any additional ablation for AF according to the standard routine of the center.

Data items will be collected, if available, consistent and applicable with routine and standard clinical care at each participating site.

Conditions

Sponsors & Collaborators

  • I-Med-Pro GmbH

    collaborator OTHER

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Gerhard Hindricks, Prof. Dr. · Herzzentrum Leipzig - Universitätsklinik

  • Kristin Ruffner, PhD · Abbott

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-05-31
Completion
2018-07-31

Countries

  • Germany
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02407249 on ClinicalTrials.gov